BioLineRX (TASE:BLRX) Q3 2026 Earnings Call
BioLineRX (TASE:BLRX) reports Q3 2026 results on this call. Live coverage runs here, and the full replay with transcript and chapters lands on this page after the call.

- Company
- BioLineRX Ltd. (TASE:BLRX)
- Period
- Q3 2026 earnings call
- Date
- Mon, Nov 23, 2026, 8:30 AM ET
On 6ix: 6ix.com/event/biolinerx-ltd-blrx-q3-2026-earnings-call
Latest news releases
- TASE:BLRX — BioLineRx and Hemispherian AS to Present Encouraging GLIX1 Preclinical Efficacy Data and its Phase 1/2a Trial Design at the 21st Meeting of the European Association of Neuro-Oncology (EANO 2026) · Thu, Sep 10, 2026
- TASE:BLRX — BioLineRx Reports First Quarter 2026 Financial Results and Provides Corporate Update · Wed, May 27, 2026